Fenster schließen  |  Fenster drucken

Das ist der nächste 100 Millionen US Dollar Deal, nur eine Frage der Zeit:


Inhaled Dry Powder
CANNABINOID PRODUCT CANDIDATES

Based on a best-in-class inhaled drug delivery platform, these product candidates combine a simple-to-use, breath-powered inhaler and cannabinoid dry powder formulations. Intended to provide ultra-rapid, precise and discreet delivery of cannabinoid medicines to the lung, without the need for heating or combustion.


Receptor Enters Into Collaboration and License Agreement with MannKind
News
January 21, 2016

Receptor Life Sciences, Inc. today announced that it has entered into a collaboration and license agreement with MannKind Corporation.

Pursuant to this agreement multiple inhaled therapeutic products will be developed to explore their potential to treat conditions such as chronic pain, neurologic diseases and inflammatory disorders.

Under the terms of the agreement, MannKind will perform initial formulation studies and will work with Receptor to develop inhaled formulations of certain undisclosed compounds. MannKind will also transfer manufacturing technology to the licensee, who will be responsible for manufacturing and commercialization activities. The parties will collaborate on the clinical development of investigational products, with Receptor being responsible for all development costs. MannKind will be eligible to receive development and commercialization milestones of up to $102.25 million as well as mid-single to low double-digit royalties on net sales of product.

"We are pleased that Receptor Life Sciences has selected our formulation and delivery technology to advance its portfolio of innovative inhaled products," said Matthew Pfeffer, Chief Executive Officer of MannKind. "This collaboration demonstrates the fundamental value of our platform technology while the risk-sharing structure of the transaction allows us to diversify our product opportunities without losing focus on our lead program."

Mannkind arbeitet jetzt mit Receptor Life Sience jetzt fast 3 Jahre zusammen, meiner Meinung nach wird bald der erste Knaller im Cannabis Bereich kommen!
 
aus der Diskussion: Mannkind, Game-Chancer in Sachen Diabetik?
Autor (Datum des Eintrages): Magnetfeldfredy  (08.11.18 07:28:43)
Beitrag: 5,070 von 6,825 (ID:59164191)
Alle Angaben ohne Gewähr © wallstreetONLINE